PATENT CLAIM ANALYSIS

Application Number: 15863216
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "221000"]

Abstract:
The present invention discloses compounds of Formula (I), and pharmaceutically acceptable salts, esters, or prodrugs thereof: These compounds are useful for treating Respiratory Syncytial Virus (RSV) infection. The present invention further relates to pharmaceutical compositions comprising these compounds for administration to a subject suffering from RSV infection. The invention also relates to methods of treating an RSV infection in a subject by administering to the subject a pharmaceutical composition comprising a compound of the invention.

Claim (Index 3):
The compound of  claim 1 , represented by Formula (IIa) or (IIb), or a pharmaceutically acceptable salt thereof: wherein R 1 , R 2 , R 3 , A, and n are as defined in  claim 1 .

Metadata:
- Claim Count in Document: 21.0
- Percentile: 86.0
- Lexical Diversity: 1.65385
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15216119', '11503502', '15772893', '14142666', '15209150']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7568415140703911
- 35 USC 102 Novelty (BERT): 0.5353720513500219
- Combined Prediction Score: 0.7346945677983542
- Mean Citation Score: 287.27602000000013
- Max Citation Score: 350.20874
- Similarity Product: 297.62980272748945

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test